SELECTIS HEALTH, INC. (GBCS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 4M 8M 12M Q3 '11: 1.3M Q4 '11: 1.2M Q1 '12: 1.3M Q3 '12: 1.3M Q4 '12: 1.2M Q1 '13: 1.2M Q3 '13: 140K Q1 '18: 812.1K Q2 '18: 902.1K Q3 '18: 885K Q4 '18: 1M Q1 '19: 1.3M Q2 '19: 1.6M Q3 '19: 2M Q4 '19: 2.1M Q1 '20: 3.9M Q2 '20: 5.1M Q3 '20: 6.3M Q4 '20: 5.6M Q1 '21: 5.8M Q2 '21: 6M Q3 '21: 7.3M Q4 '21: 10.2M Q1 '22: 10.1M Q2 '22: 11.5M Q3 '22: 9.6M Q4 '22: 10.8M Q1 '23: 9.6M Q2 '23: 8.9M Q3 '23: 9M Q4 '23: 9.2M Q1 '24: 9.5M Q2 '24: 9.6M Q3 '24: 10M Q4 '24: 10.4M Q1 '25: 10.5M Q2 '25: 10.4M Q3 '25: 10.8M Q4 '25: 9.7M Q1 '26: 7.3M Q4 '12 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-3M -1.5M 0 1.5M 3M 4.5M Q4 '15: -2.2M Q1 '16: -420.8K Q2 '16: 873K Q3 '16: -215K Q4 '16: -294.8K Q1 '17: -87.4K Q2 '17: 132.1K Q3 '17: 86.9K Q4 '17: 333K Q1 '18: 280.7K Q2 '18: 86.2K Q3 '18: 156.9K Q1 '19: 409.5K Q2 '19: 370.3K Q3 '19: 634.3K Q1 '20: 568.1K Q2 '20: 1.7M Q3 '20: 987K Q4 '20: 168.3K Q1 '21: -305.4K Q2 '21: 2.1K Q3 '21: 736.7K Q4 '21: -1.2M Q1 '22: 615.9K Q2 '22: 1.3M Q3 '22: -322.3K Q4 '22: -1.9M Q1 '23: -2M Q2 '23: -1.6M Q3 '23: -2.4M Q4 '23: -3M Q1 '24: -696.3K Q2 '24: -763.9K Q3 '24: -1.2M Q4 '24: -97.3K Q1 '25: -421.7K Q2 '25: -450.3K Q3 '25: -297K Q4 '25: -395.7K Q1 '26: -1.3M Q4 '16 Q1 '18 Q3 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Net Income Quarterly

-5M -2.5M 0 2.5M 5M 7.5M Q2 '16: 423.2K Q3 '16: 355.8K Q4 '16: -855.3K Q1 '17: -561.9K Q2 '17: -339.3K Q3 '17: -449K Q4 '17: -1.6M Q1 '18: -204.3K Q2 '18: -484.8K Q3 '18: -419K Q4 '18: -884K Q1 '19: 164.3K Q2 '19: -168.3K Q3 '19: 184.1K Q4 '19: -1M Q1 '20: 61.1K Q2 '20: 1.1M Q3 '20: 466.7K Q4 '20: 1.3M Q1 '21: 248.1K Q2 '21: -678.8K Q3 '21: -53K Q4 '21: -1.8M Q1 '22: 37.1K Q2 '22: 750.2K Q3 '22: -990.9K Q4 '22: -2.2M Q1 '23: 4M Q2 '23: -2.1M Q3 '23: -2.3M Q4 '23: -3.6M Q1 '24: -1M Q2 '24: 794.3K Q3 '24: -1.6M Q4 '24: -576.5K Q1 '25: -656K Q2 '25: -308K Q3 '25: 752.4K Q4 '25: -804.1K Q1 '26: 6.5M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q2 '15: 43.6K Q3 '15: 49.5K Q1 '16: -126K Q2 '16: -145.1K Q3 '16: -235.2K Q4 '16: -675 Q1 '17: -101.8K Q2 '17: -49.9K Q3 '17: 255.4K Q4 '17: 114.5K Q1 '18: 208.3K Q2 '18: 65.3K Q3 '18: 130.4K Q1 '19: 266.1K Q2 '19: 134.7K Q3 '19: 354.3K Q4 '19: 113.8K Q1 '20: 252.4K Q2 '20: 1.2M Q3 '20: 1.5M Q1 '21: -664.8K Q2 '21: 22.5K Q3 '21: -962.4K Q4 '21: 1.3M Q1 '22: -1.2M Q2 '22: 1.3M Q3 '22: -752.1K Q4 '22: 345.5K Q1 '23: -67K Q2 '23: 99.6K Q3 '23: 2.4M Q1 '24: 249.5K Q2 '24: -422.9K Q3 '24: -1.2M Q4 '24: -423.4K Q1 '25: 1M Q2 '25: -77.4K Q3 '25: 280K Q4 '25: 644K Q1 '26: -2.3M Q3 '16 Q4 '17 Q2 '19 Q3 '20 Q1 '22 Q2 '23 Q4 '24 Q1 '26

Free Cash Flow Quarterly

-3M -2M -1M 0 1M 2M 3M Q1 '13: 124.1K Q1 '14: -2.6M Q2 '14: -897.7K Q3 '14: -2.9M Q4 '14: 32.2K Q1 '15: 219.1K Q2 '15: -221.3K Q3 '15: 42.6K Q3 '16: -235.2K Q4 '16: -300.7K Q3 '17: -172.5K Q4 '17: -177.1K Q1 '18: 64.9K Q2 '18: -354.3K Q3 '18: 128.4K Q1 '19: -696.1K Q2 '19: -367.6K Q3 '19: -47.9K Q1 '20: 212.3K Q2 '20: 1M Q3 '20: 865.2K Q1 '21: -842.8K Q2 '21: -195.2K Q3 '21: -1.1M Q4 '21: 1.3M Q1 '22: -1.3M Q2 '22: 1.3M Q3 '22: -991.7K Q1 '23: -109.5K Q2 '23: 99.6K Q3 '23: 2.3M Q1 '24: 132.9K Q2 '24: -512.7K Q3 '24: -1.2M Q4 '24: -433.2K Q1 '25: 816.2K Q2 '25: -240.9K Q3 '25: 275.8K Q4 '25: 587.3K Q1 '26: -2.7M Q4 '14 Q4 '16 Q3 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 10M 20M 30M Q1 '12: 6.8M Q2 '13: 7.1M Q3 '13: 7.3M Q1 '14: 19.8M Q2 '14: 19.7M Q3 '14: 20M Q1 '15: 21.8M Q2 '15: 22M Q3 '15: 22.3M Q1 '16: 22.5M Q2 '16: 23.1M Q3 '16: 23.4M Q1 '17: 25.3M Q2 '17: 25.7M Q3 '17: 25.9M Q1 '18: 26.7M Q2 '18: 27M Q3 '18: 27.1M Q1 '19: 26.9M Q2 '19: 27.3M Q3 '19: 27.4M Q1 '20: 27.4M Q2 '20: 27.8M Q3 '20: 3.1M Q1 '21: 2.8M Q2 '21: 2.7M Q3 '21: 2.8M Q1 '22: 3.1M Q2 '22: 3.1M Q3 '22: 3.1M Q1 '23: 3.1M Q2 '23: 3.1M Q3 '23: 3.1M Q1 '24: 3.1M Q2 '24: 3.1M Q3 '24: 3.1M Q1 '25: 3.1M Q2 '25: 3.1M Q3 '25: 3.1M Q1 '26: 3.4M Q2 '14 Q1 '16 Q3 '17 Q2 '19 Q1 '21 Q3 '22 Q2 '24 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '15: -0.07 Q3 '15: -0.09 Q4 '15: -0.15 Q1 '16: -0.19 Q2 '16: -0.16 Q3 '16: -0.12 Q4 '16: -0.06 Q1 '17: -0.03 Q2 '17: -0.06 Q3 '17: -0.09 Q4 '17: -0.12 Q1 '18: -0.11 Q2 '18: -0.12 Q3 '18: -0.12 Q4 '18: -0.09 Q1 '19: -0.07 Q2 '19: -0.06 Q3 '19: -0.03 Q4 '19: -0.03 Q1 '20: -0.04 Q2 '20: 0.01 Q3 '20: 0.15 Q4 '20: 0.61 Q1 '21: 0.70 Q2 '21: 0.40 Q3 '21: 0.23 Q4 '21: -0.83 Q1 '23: 0.61 Q2 '23: -0.42 Q3 '23: -0.83 Q4 '23: -1.31 Q1 '24: -2.97 Q2 '24: -2.02 Q3 '24: -1.80 Q4 '24: -0.80 Q1 '25: -0.68 Q2 '25: -1.04 Q3 '25: -0.28 Q4 '25: -0.34 Q1 '26: 1.78 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '23 Q4 '24 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.